相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Faster, better, stronger: Towards new antidepressant therapeutic strategies
Olivia F. O'Leary et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia
Ghanshyam N. Pandey et al.
BIPOLAR DISORDERS (2015)
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment
Aline Siqueira Ferreira et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
Lily L. Remsing Rix et al.
ACS CHEMICAL BIOLOGY (2014)
Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
Tiago Silva et al.
AGEING RESEARCH REVIEWS (2014)
Health Outcomes and Cost of Care Among Older Adults with Schizophrenia: A 10-Year Study Using Medical Records Across the Continuum of Care
Hugh C. Hendrie et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Glycogen Synthase Kinase 3 Beta Gene Structural Variants as Possible Risk Factors of Bipolar Depression
Zsolt Ronai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)
Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice
Sorabh Sharma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
Aimee V. Franklin et al.
BIOLOGICAL PSYCHIATRY (2014)
Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease
Susan A. Farr et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Association of GSK-3β Genetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
Giuseppe Blasi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease
Min-Young Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: What do we know?
Susan W. Lehmann et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium
Yen-Feng Lin et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
Limor Avrahami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Inhibition of GSK3 beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Philip T. T. Ly et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice
Matthew R. King et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression
Philip Cowen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
HIV-associated neurocognitive disorder
David B. Clifford et al.
LANCET INFECTIOUS DISEASES (2013)
GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis
Hui Tang et al.
MOLECULAR NEUROBIOLOGY (2013)
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice
Tatiana V. Lipina et al.
NEUROPHARMACOLOGY (2013)
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
Breno Satler Diniz et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo
Jose A. Morales-Garcia et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
V. V. Dias et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Requirement of adult-born neurons for hippocampus-dependent learning
Antonia Marin-Burgin et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Biphasic Dose-Dependent Effect of Lithium Chloride on Survival of Human Hormone-Dependent Breast Cancer Cells (MCF-7)
Muralidharan Suganthi et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2012)
Functional significance of glycogen synthase kinase-3 regulation by serotonin
Abigail M. Polter et al.
CELLULAR SIGNALLING (2012)
Does Lithium Prevent Alzheimerʼs Disease?
Orestes V. Forlenza et al.
DRUGS & AGING (2012)
Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome
Weixiang Guo et al.
HUMAN MOLECULAR GENETICS (2012)
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Juan Manuel Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
David E. Hurtado et al.
JOURNAL OF NEUROSCIENCE (2012)
Lithium Reduces BACE1 Overexpression, Beta Amyloid Accumulation, and Spatial Learning Deficits in Mice with Traumatic Brain Injury
Fengshan Yu et al.
JOURNAL OF NEUROTRAUMA (2012)
A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
Jean-Martin Beaulieu
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2012)
GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
Holly F. Green et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Lithium Treatment of APPSwDI/NOS2-/- Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
Tiffany L. Sudduth et al.
PLOS ONE (2012)
The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
Wenjun Zhou et al.
PLOS ONE (2012)
Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
Ming-Huan Chan et al.
SCHIZOPHRENIA RESEARCH (2012)
Enhanced Lithium-Induced Brain Recovery Following Cranial Irradiation Is Not Impeded by Inflammation
Jordane Malaterre et al.
STEM CELLS TRANSLATIONAL MEDICINE (2012)
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
Orestes V. Forlenza et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities
Valle Palomo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease
Tomohiro Onishi et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Glycogen Synthase Kinase-3β Is a Functional Modulator of Serotonin-1B Receptors
L. Chen et al.
MOLECULAR PHARMACOLOGY (2011)
THE EFFECTS OF NEUROPSYCHIATRIC DRUGS ON GLYCOGEN SYNTHASE KINASE-3 SIGNALING
L. P. Sutton et al.
NEUROSCIENCE (2011)
Indirubin-3′-oxime inhibits inflammatory activation of rat brain microglia
Hoon-Ji Jung et al.
NEUROSCIENCE LETTERS (2011)
Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress
Sung Woo Park et al.
NEUROSCIENCE RESEARCH (2011)
Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome
Pramod K. Dash et al.
PLOS ONE (2011)
Glycogen synthase kinase-3: a promising therapeutic target for fragile X syndrome
Marjelo A. Mines et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
GSK-3: functional insights from cell biology and animal models
Oksana Kaidanovich-Beilin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
GSK-3 inhibitors: preclinical and clinical focus on CNS
Hagit Eldar-Finkelman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
Christopher J. Yuskaitis et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Regulation of glycogen synthase kinase-3 during bipolar mania treatment
Xiaohong Li et al.
BIPOLAR DISORDERS (2010)
Does lithium protect against dementia?
Lars Vedel Kessing et al.
BIPOLAR DISORDERS (2010)
Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice
Zu-Fu Zhu et al.
BRAIN RESEARCH BULLETIN (2010)
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity
F. Benedetti et al.
GENES BRAIN AND BEHAVIOR (2010)
Excellent lithium responders have normal cognitive functions and plasma BDNF levels
Janusz K. Rybakowski et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Risk factors for cognitive impairment in elderly bipolar patients
Sigfried N. T. M. Schouws et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder
Carlos Lopez-Jaramillo et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
E. M. Toledo et al.
MOLECULAR PSYCHIATRY (2010)
Emerging roles of Wnts in the adult nervous system
Nibaldo C. Inestrosa et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Elena Gomez de Barreda et al.
NEUROBIOLOGY OF DISEASE (2010)
Indirubin-3′-monoxime rescues spatial memory deficits and attenuates β-amyloid-associated neuropathology in a mouse model of Alzheimer's disease
Yun Ding et al.
NEUROBIOLOGY OF DISEASE (2010)
Novel Insights into Lithium's Mechanism of Action: Neurotrophic and Neuroprotective Effects
Jorge A. Quiroz et al.
NEUROPSYCHOBIOLOGY (2010)
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Xiaohua Li et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice
Anna Fiorentini et al.
PLOS ONE (2010)
Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β
Morihisa Saitoh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Identifying and treating cognitive impairment in bipolar disorder
Joseph F. Goldberg et al.
BIPOLAR DISORDERS (2009)
Molecular Pathology of Neuro-AIDS (CNS-HIV)
Leslie Crews et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
GSK-3: A Key Player in Neurodegeneration and Memory
Karl Peter Giese
IUBMB LIFE (2009)
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
Harald Hampel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Effects of Lithium on Cognitive Performance: A Meta-Analysis
Aliza P. Wingo et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability
Morihisa Saitoh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3
Ligong Chen et al.
MOLECULAR PHARMACOLOGY (2009)
GSK3β, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9
I. Dewachter et al.
NEUROBIOLOGY OF DISEASE (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential
Wenzhong William Min et al.
NEUROPHARMACOLOGY (2009)
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
Kaushik Ghosal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lithium treatment in Alzheimer's disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects
Nunzio Pomara
PSYCHOPHARMACOLOGY (2009)
Neuropsychological profile in bipolar disorder:: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval
M. Mur et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Wnt signaling in neural circuit assembly
Patricia C. Salinas et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Glycogen synthase kinase-3β heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action:: negative results
Yuly Bersudsky et al.
BEHAVIOURAL PHARMACOLOGY (2008)
AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families
Dawn L. Thiselton et al.
BIOLOGICAL PSYCHIATRY (2008)
Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma
Jonathan B. Savitz et al.
BIPOLAR DISORDERS (2008)
Inhibition of glycogen synthase kinase 30 attenuates neurocognitive dysfunction resulting from cranial irradiation
Dinesh K. Thotala et al.
CANCER RESEARCH (2008)
Antidepressant drugs and memory: Insights from animal studies
Santiago Monleon et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome
Elizabeth Berry-Kravis et al.
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2008)
GSK-3β Is Required for Memory Reconsolidation in Adult Brain
Tetsuya Kimura et al.
PLOS ONE (2008)
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Jean-Martin Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest
Jin-Sheng Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Activation of glycogen synthase kinase-3 inhibits LongTerm Potentiation with synapse-associated impairments
Ling-Qiang Zhu et al.
JOURNAL OF NEUROSCIENCE (2007)
Augmentation strategies for treatment-resistant depression: a literature review
A. F. Carvalho et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents
Abbas Shakoori et al.
CANCER SCIENCE (2007)
Persistent neuropsychological deficit in euthymic bipolar patients:: Executive function as a core deficit
Maria Mur et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex
Myoung-Sun Roh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer
Aijing Sun et al.
PROSTATE (2007)
Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate
Vesile Senturk et al.
BIPOLAR DISORDERS (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Increase in GSK3β gene copy number variation in bipolar disorder
Herbert M. Lachman et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder
Paula V. Nunes et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Lithium regulates glycogen synthase kinase-3β in human peripheral blood mononuclear cells:: Implication in the treatment of bipolar disorder
Xiaohua Li et al.
BIOLOGICAL PSYCHIATRY (2007)
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone et al.
TRENDS IN NEUROSCIENCES (2007)
Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation
Eugenia M. Yazlovitskaya et al.
CANCER RESEARCH (2006)
Age-related changes in glycogen synthase kinase 3β (GSK3β) immunoreactivity in the central nervous system of rats
Soo Joo Lee et al.
NEUROSCIENCE LETTERS (2006)
Lithium improves HIV-associated neurocognitive impairment
Scott L. Letendre et al.
AIDS (2006)
Lithium and dementia: A preliminary study
Takeshi Terao et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3
Tobias Engel et al.
JOURNAL OF NEUROSCIENCE (2006)
No association of two common SNPs at position-1727 A/T,-50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population
KY Lee et al.
NEUROSCIENCE LETTERS (2006)
Association analysis of the glycogen synthase kinase-3β gene in bipolar disorder
N Nishiguchi et al.
NEUROSCIENCE LETTERS (2006)
Association analysis of the GSK-3 beta T-50C gene polymorphism with schizophrenia and bipolar disorder
A Szczepankiewicz et al.
NEUROPSYCHOBIOLOGY (2006)
Wnt signalling regulates adult hippocampal neurogenesis
DC Lie et al.
NATURE (2005)
Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families
SG Schwab et al.
BIOLOGICAL PSYCHIATRY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β -50 T/C SNP
F Benedetti et al.
NEUROSCIENCE LETTERS (2005)
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
H Alimohamad et al.
BIOLOGICAL PSYCHIATRY (2005)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
1-azakenpaullone is a selective inhibitor of glycogen synthase kinase-3β
C Kunick et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain
XH Li et al.
NEUROPSYCHOPHARMACOLOGY (2004)
GSK-3β in cerebrospinal fluid of schizophrenia patients
N Kozlovsky et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients
C Nadri et al.
SCHIZOPHRENIA RESEARCH (2004)
Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients
N Kozlovsky et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Association of AKT1 with schizophrenia confirmed in a Japanese population
M Ikeda et al.
BIOLOGICAL PSYCHIATRY (2004)
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects
LL Altshuler et al.
BIOLOGICAL PSYCHIATRY (2004)
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418
R Bhat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3
B Plotkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The effects of lithium on cognition: an updated review
AK Pachet et al.
PSYCHOPHARMACOLOGY (2003)
Activation of Wnt signaling and behavioral impairments rescues neurodegeneration induced by beta-amyloid fibrils
GV De Ferrari et al.
MOLECULAR PSYCHIATRY (2003)
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments
F Hernández et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
GSK-3 parameters in lymphocytes of schizophrenic patients
C Nadri et al.
PSYCHIATRY RESEARCH (2002)
GSK3β signalling:: Casting a wide net in Alzheimer's disease
RV Bhat et al.
NEUROSIGNALS (2002)
Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain
HB Yao et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2002)
Disruption of CREB function in brain leads to neurodegeneration
T Mantamadiotis et al.
NATURE GENETICS (2002)
Sustained attention deficit in bipolar disorder
L Clark et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
A Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Low GSK-3 activity in frontal cortex of schizophrenic patients
N Kozlovsky et al.
SCHIZOPHRENIA RESEARCH (2001)
CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium
CA Grimes et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Glycogen synthase kinase-3β regulates presenilin 1 C-terminal fragment levels
F Kirschenbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
R Dajani et al.
CELL (2001)
Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia
C Beasley et al.
NEUROSCIENCE LETTERS (2001)
Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder
SM El-Badri et al.
BIPOLAR DISORDERS (2001)
Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease -: A property common to most cycline-dependent kinase inhibitors?
S Leclerc et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular targets of lithium action
CJ Phiel et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
XJ Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
N Kozlovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Differential pharmacokinetics of lithium in elderly patients
BA Sproule et al.
DRUGS & AGING (2000)
分享论文
